Published in Nat Rev Nephrol on May 27, 2014
The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol (2015) 0.86
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clin J Am Soc Nephrol (2015) 0.83
Obesity-Related Chronic Kidney Disease-The Role of Lipid Metabolism. Metabolites (2015) 0.83
Pathophysiology of Non Alcoholic Fatty Liver Disease. Int J Mol Sci (2016) 0.81
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans. BMC Genomics (2015) 0.79
TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Am J Physiol Renal Physiol (2015) 0.78
Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial. J Am Soc Nephrol (2016) 0.78
Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol (2015) 0.77
Apolipoprotein L1, income and early kidney damage. BMC Nephrol (2015) 0.77
Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. J Clin Invest (2016) 0.76
Podocyte Purinergic P2X4 Channels Are Mechanotransducers That Mediate Cytoskeletal Disorganization. J Am Soc Nephrol (2015) 0.76
Distinct urinary lipid profile in children with focal segmental glomerulosclerosis. Pediatr Nephrol (2015) 0.76
Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes. PLoS One (2015) 0.75
Lipoprotein X Causes Renal Disease in LCAT Deficiency. PLoS One (2016) 0.75
FAK contributes to proteinuria in hypercholesterolaemic rats and modulates podocyte F-actin re-organization via activating p38 in response to ox-LDL. J Cell Mol Med (2016) 0.75
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease. Int J Nephrol (2017) 0.75
Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease. PLoS One (2017) 0.75
Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts. Sci Rep (2017) 0.75
A kidney-specific genome-scale metabolic network model for analyzing focal segmental glomerulosclerosis. Mamm Genome (2016) 0.75
Functional rafts in cell membranes. Nature (1997) 38.89
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 16.41
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Protein sensors for membrane sterols. Cell (2006) 8.62
Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A (1999) 7.48
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
The insulin signaling system. J Biol Chem (1994) 5.25
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (2011) 4.80
Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res (1997) 4.44
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Obesity-related glomerulopathy: an emerging epidemic. Kidney Int (2001) 3.98
Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 3.22
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care (2003) 3.12
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab (2012) 2.76
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol (2012) 2.75
Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int (2001) 2.73
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem (2002) 2.61
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol (2012) 2.58
Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia (1999) 2.55
Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem (1997) 2.53
Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem (2008) 2.30
Meta-analysis: the effect of statins on albuminuria. Ann Intern Med (2006) 2.19
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A (2006) 2.16
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int (2002) 2.15
Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes (2002) 2.12
Intracellular cholesterol transport. J Clin Invest (2002) 2.12
Cyclodextrins. Toxicol Pathol (2008) 2.11
Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int (2007) 2.05
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem (2005) 2.05
Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest (2007) 2.04
Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet (1993) 1.95
ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death. Autophagy (2008) 1.87
Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res (2013) 1.82
Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell (2012) 1.79
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol (2009) 1.77
Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem (2001) 1.74
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes (2005) 1.70
Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet (2008) 1.69
Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. Proc Natl Acad Sci U S A (2009) 1.69
Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol Dial Transplant (2009) 1.68
Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol (2011) 1.66
Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes (2006) 1.64
The trypanolytic factor of human serum. Nat Rev Microbiol (2006) 1.64
The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis (2010) 1.50
Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). Am J Kidney Dis (2009) 1.45
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes (1998) 1.45
Insulin signaling in microdomains of the plasma membrane. Traffic (2003) 1.44
Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes (2006) 1.40
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39
Renal pathology in Fabry disease. J Am Soc Nephrol (2002) 1.34
Retracted Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance. Mol Endocrinol (2007) 1.34
Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association. Int J Nephrol (2012) 1.31
The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep (2009) 1.29
Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes (2010) 1.29
Cellular cholesterol efflux. Biochim Biophys Acta (2001) 1.27
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. Nephrol Dial Transplant (2010) 1.26
Cellular cholesterol efflux to serum is impaired in diabetic nephropathy. Diabetes Metab Res Rev (2008) 1.25
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int (2010) 1.25
Control of angiogenesis by AIBP-mediated cholesterol efflux. Nature (2013) 1.21
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? J Lipid Res (2012) 1.19
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol (2009) 1.16
Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol (2005) 1.16
Defective cholesterol trafficking in Niemann-Pick C-deficient cells. FEBS Lett (2010) 1.16
A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus. J Clin Invest (1993) 1.15
Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int (2008) 1.14
HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux. J Lipid Res (2012) 1.11
Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor? Curr Atheroscler Rep (2011) 1.09
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res (2013) 1.09
HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens (2011) 1.07
Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol (2010) 1.07
Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans. Trends Cardiovasc Med (2010) 1.03
A cell-type specific ganglioside of glomerular podocytes in rat kidney: an O-acetylated GD3. Kidney Int (1992) 1.02
Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res (2009) 1.02
Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity. Obes Rev (2009) 1.02
Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol (2009) 1.01
Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med (2009) 1.01
Glomerular endothelial fenestrae in vivo are not formed from caveolae. J Am Soc Nephrol (2002) 1.01
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL. J Lipid Res (2008) 1.00
Sphingomyelinase activates GLUT4 translocation via a cholesterol-dependent mechanism. Am J Physiol Cell Physiol (2003) 0.99
Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors. Cytokine (2012) 0.99
Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metab Cardiovasc Dis (2010) 0.98
Effects of statins on renal function. Am J Cardiol (2006) 0.96
Isoform-specific insulin receptor signaling involves different plasma membrane domains. J Cell Biol (2003) 0.96
Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli. Arterioscler Thromb Vasc Biol (1999) 0.96